Sex Proportionality in Pre-clinical and Clinical Trials: An Evaluation of 22 Marketing Authorization Application Dossiers Submitted to the European Medicines Agency

This study assessed to what extent women were included in all phases of drug development; whether the clinical studies in the marketing authorization application dossiers include information per sex; and explored whether there are differences between women and men in the drugs' efficacy and saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Dekker, Marieke J. H. J., de Vries, Sieta T., Versantvoort, Carolien H. M., Drost-van Velze, Ellen G. E., Bhatt, Mansi, van Meer, Peter J. K., Havinga, Ineke K., Gispen-de Wied, Christine C., Mol, Peter G. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006272/
https://www.ncbi.nlm.nih.gov/pubmed/33791329
http://dx.doi.org/10.3389/fmed.2021.643028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006272/
https://www.ncbi.nlm.nih.gov/pubmed/33791329
http://dx.doi.org/10.3389/fmed.2021.643028

Ejemplares similares